Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 1 | 1 | 33 | 33 |
| Average estimate | 7.44 | 8.10 | 35.39 | 39.04 |
| Low estimate | 7.44 | 8.10 | 29.30 | 32.06 |
| High estimate | 7.44 | 8.10 | 40.40 | 47.90 |
| Last year EPS | 10.13 | 9.35 | 37.88 | 35.39 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 1 | 1 | 29 | 29 |
| Avg. estimate | 155.90B | 157.60B | 650.79B | 719.09B |
| Low estimate | 155.90B | 157.60B | 609B | 649.16B |
| High estimate | 155.90B | 157.60B | 682.48B | 787.42B |
| Last year sales | 168.03B | 151.86B | 623.06B | 650.79B |
| Sales growth | -0.07 | 0.04 | 0.04 | 0.11 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 7.44 | 8.10 | 35.39 | 39.04 |
| 7 days ago | 7.80 | 7.65 | 35.42 | 38.91 |
| 30 days ago | 7.80 | 7.65 | 35.27 | 38.62 |
| 60 days ago | 7.25 | 8.58 | 35.29 | 38.36 |
| 90 days ago | 7.52 | 8.09 | 35.75 | 38.63 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 1 | 0 | 3 | 1 |
| Up last 30 days | 1 | 0 | 5 | 4 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 1 | 8 | 7 |